Quantification and long-term carriage study of human extended-spectrum/AmpC β-lactamase-producing Escherichia coli after international travel to Vietnam.
Extended-spectrum β-lactamase and AmpC β-lactamase-producingEscherichia coli (ESBL/AmpC-E. coli) are common in developing countries, and travelers represent potential reservoirs for their dissemination. Our aim was to quantify cefotaxime (CTX)-resistant E. coli harbored by travelers to Vietnam, and to conduct a follow-up study. In total, 19 travelers and 34 travel events were investigated. After confirming that travelers were not colonized with CTX-resistantE. coli before travel, 15 travelers and 20 travel events were studied to quantify travelers harboring CTX-resistant E. coli after travel. A total 0.1 g of stool in 10 mL of PBS was diluted and plated. Selected colonies were identified, genotyped and further verified by pulse-field-gel electrophoresis (PFGE). After travel, travelers harbored an average of 3.6 × 107 CFU/g feces of CTX-resistant E. coli, which continued to be detected for an average of 14 weeks. In the follow-up study, travelers from two travel events had ESBL-E. coli for 12 months. Multiplex PCR showed blaCTX-M-55 and blaCTX-M-27, with replicon types FIA and F, and FIB and F, respectively. PFGE showed that two travelers harbored a single clonal strain of ESBL-E. coli for 12 months. Using PFGE, the follow-up study showed that a single type of ESBL/AmpC-E. coli was only detected in individuals living in Japan. Moreover, the same clonal ESBL-E. coli isolate was detected in a group that traveled to Ho Chi Minh City. ESBL/AmpC-E. coli colonized the gut of travelers to Vietnam with a CTX-resistant E. coli (>107 CFU/g feces), and the colonization lasted 14 weeks.